{"id":372274,"title":"Guidance documents: Biologics, radiopharmaceuticals, cell and gene therapies - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T16:30:29.287000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents.html","snippet":"Guidance documents: Biologics, radiopharmaceuticals, cell and gene therapies The following guidance documents have been prepared to assist in the interpretation of the policies governing statutes and regulations. Consultation: Draft guidance on decentralized clinical trials…","rawSnapshotUrl":"/api/snapshots/raw/372274","browseUrl":"https://replay.healtharchive.ca/job-6/20260411163029/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents.html#ha_snapshot=372274","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}